Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;81(5):816-846.
doi: 10.1016/j.jinf.2020.07.028. Epub 2020 Jul 30.

Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study

Affiliations
Comment

Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study

Annaelle Chetrit et al. J Infect. 2020 Nov.

Abstract

  1. COVID-19 patients with total loss of smell have more olfactory bulb abnormalities at the magnetic resonance imaging than patients without loss of smell.

  2. The olfactory bulb MRI abnormalities may be objectified through a signal intensity ratio measurement that is calculated between the average signals of the olfactory bulb and the frontal white matter.

  3. The loss of smell is probably due to olfactory bulb inflammation related to virus spread.

Keywords: Anosmia; COVID-19; Coronavirus; Imaging; MRI; Olfaction; Olfactory; Smell.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest.

Figures

Fig. 1
Fig. 1
MRI findings. Comparison of T2/FLAIR coronal views centered on the olfactory bulbs showing normal signal in a normosmic (A) and T2/FLAIR hyperintensity of the olfactory bulbs in a patient with anosmia (B). Box plot (C) of signal intensity ratio in loss of smell and in normo-osmic group, revealing a statistically higher T2/FLAIR Signal Intensity Ratio of the olfactory bulb in the loss of smell group (p<0.001).

Comment on

References

    1. Salmon D., Bartier S., Hautefort C., Nguyen Y., Nevoux J., Hamel A.L., Camhi Y., Canouï-Poitrine F., Verillaud B., Slama D., Haim-Boukobza S., Sourdeau E., Cantin D., Corré A., Bryn A., Etienne N., Rozenberg F., Layese R., Papon J.F., Bequignon E., APHP COVID-19 research collaboration Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study. J Infect. 2020 Jul 7 doi: 10.1016/j.jinf.2020.07.005. S0163-4453(20)30463-1. - DOI - PMC - PubMed
    1. Lechien J.R., Chiesa-Estomba C.M., Hans S. Loss of Smell and Taste in 2,013 European Mild-to-Moderation COVID-19 Patients. Ann Int Med. 2020 doi: 10.7326/M20-2428. - DOI - PMC - PubMed
    1. Lechien J.R., Cabaraux P., Chiesa-Estomba C.M. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020 doi: 10.1002/hed.26279. - DOI - PMC - PubMed
    1. Rawal S., Hoffman H.J., Bainbridge K.E., Huedo-Medina T.B., Duffy V.B. Prevalence and Risk Factors of Self-Reported Smell and Taste Alterations: results from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES) Chem Sens. 2016;41(1):69–76. doi: 10.1093/chemse/bjv057. - DOI - PMC - PubMed
    1. Chung M.S., Choi W.R., Jeong H.Y., Lee J.H., Kim J.H. MR imaging-based evaluations of olfactory bulb atrophy in patients with olfactory dysfunction. AJNR Am J Neuroradiol. 2018;39(3):532–537. doi: 10.3174/ajnr.A5491. - DOI - PMC - PubMed